The first two pieces made the case that PMOS-history women hit perimenopause with less metabolic reserve than average, and that the compounding risk shows up in specific, identifiable ways — vasomotor symptom severity, body composition changes, an earlier cardiovascular risk clock. (Quick reminder: PMOS, polyendocrine metabolic ovarian syndrome, is the new name for PCOS — I’m using PMOS through this series, with PCOS alongside it for clarity.) This piece is about what to actually do with that information, because “be aware of it” isn’t a plan.
Why the standard structure fails this transition specifically
Most women move between two disconnected systems: a reproductive endocrinologist or OB/GYN manages PMOS during reproductive years, then somewhere in the 40s, care shifts toward primary care or a menopause-focused provider for the transition. Nothing in that handoff is designed to carry forward a PMOS-specific risk profile. The new provider typically starts from population-average perimenopause risk, not from “this patient has had two decades of elevated insulin resistance and needs a different monitoring baseline.”
That’s a structural gap, not a clinician failure. Nobody built the connective tissue between these two phases of care because they’re conventionally treated as separate conditions rather than one continuous metabolic story — and the fact that one of them just changed its name doesn’t fix that on its own.
What should actually be different, starting in the late 30s to early 40s
Earlier and more frequent metabolic monitoring. Fasting insulin and HOMA-IR, not just fasting glucose, tracked starting before perimenopausal symptoms even begin — establishing a real baseline rather than waiting for symptoms to trigger testing.
Cardiovascular risk assessment on an earlier timeline. Given the mechanistic overlap between PMOS-related and perimenopause-related cardiovascular risk factors, standard age-based screening triggers likely aren’t the right threshold for this population. Lipid panels and blood pressure trends deserve earlier and more frequent attention than population guidelines default to. [likely]
Vasomotor symptom severity treated as a metabolic signal, not just a comfort issue. Given the association between insulin resistance and vasomotor symptom severity, a woman with a PMOS history reporting unusually severe hot flashes may be reporting a metabolic escalation worth investigating, not just a quality-of-life complaint to manage symptomatically.
Body composition tracked with context, not just a scale number. The same amount of visceral fat gain likely means something different in a woman with two decades of prior insulin resistance than in a woman without that history — composition and trend matter more than a single weight or BMI number. [likely]
Continuity of care across the transition. The single highest-leverage fix is probably the simplest: a woman’s PMOS (PCOS) history should travel with her into perimenopause management as an active risk factor, not a closed chapter in an old chart. That requires either a single provider managing both phases, or a deliberate handoff that transfers the actual risk context, not just a diagnosis code.
Why this is a build problem, not just an awareness problem
Everything above requires a care structure willing to treat this transition as continuous rather than as two separate hand-offs — which is a genuinely different model than most existing menopause or PMOS care pathways are built around. That’s the specific gap I’ve been working on with the menopause program we’re developing at ProvationLife: designed explicitly around carrying a woman’s metabolic history forward instead of starting her risk assessment over at 45.
The throughline across this series
PMOS and perimenopause have been treated as two different chapters of a woman’s life, managed by two different parts of the healthcare system, using two different playbooks. The biology doesn’t actually support that split, and a new name for the first chapter doesn’t change the structural gap between them. It’s one metabolic story, and the transition between its two halves is exactly where care most often falls through the gap.
Medical Disclaimer
The information provided in this blog post and newsletter is for educational and informational purposes only. It does not constitute medical advice or professional services and should not be used to diagnose or treat any health problem or disease. Always seek the advice of your physician or other qualified health‑care provider regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read here.
Use of this content does not create a doctor–patient relationship. Individual responses to treatments and lifestyle changes can vary, and only your healthcare provider can evaluate your specific circumstances. If you are experiencing a medical emergency, call your local emergency services immediately.